Saatchis fights to keep Xian Janssen brands

Johnson & Johnson JV Xian Janssen is reviewing its creative accounts for its Daktarin and Pevisone brands, with at least four agencies believed to be in the running. The combined value of the business is estimated at Rmb 100 million (US$15 million).